Login to Your Account

Financings Roundup

Wednesday, June 26, 2013
Bluebird Bio Inc., of Cambridge, Mass., closed its initial public offering of about 6.8 million shares at $17 each, which includes the exercise in full by the underwriters of their option to purchase up to 891,176 additional shares.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription